Results 201 to 210 of about 100,010 (342)
An oral nanoplatform, MOP@T@D, which can maintain glucose homeostasis and restore islet β cells in diabetic rats is developed. It achieves efficient intestinal absorption and liver‐targeted delivery. The nanoparticle disintegrates only in response to hyperglycemia to release insulin on demand and provides antioxidant protection through selenoprotein ...
Chenxiao Chu +14 more
wiley +1 more source
Antibody-Drug Conjugates in Hematological Malignancies: Current Landscape and Future Perspectives. [PDF]
Montalbano MC +3 more
europepmc +1 more source
Supplementary Figure S6 from Endo180 (<i>MRC2</i>) Antibody–Drug Conjugate for the Treatment of Sarcoma [PDF]
Rachel J. Evans +7 more
openalex +1 more source
Synthetic Nanobiology Actuated Lipometabolic Cell Factory for Autologous Tumor Immunotherapy
FA plays a crucial role in the interaction between tumor cells and the tumor microenvironment, especially for the immune response. A biocatalytic immunoenhancement strategy is developed to boost antitumor immunity by FA metabolic orientation to ceramide. Through the design of this delicate catalytic immunoenhancement strategy, the synthetic nanobiology
Shoujie Zhao +8 more
wiley +1 more source
Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. [PDF]
Wang H +6 more
europepmc +1 more source
Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates [PDF]
Lily Liu-Shin +3 more
openalex +1 more source
Metabolic changes in immune cells direct the phenotype and function of the host immune system. Smart nanomaterials must target metabolic pathways to direct immune cell fate. This study reports the fabrication and first application of germanane quantum dots (GeHQDs) to modulate inflammation in vitro and in vivo.
Abhay Srivastava +7 more
wiley +1 more source
Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologies. [PDF]
Feng C +7 more
europepmc +1 more source

